Scientific Advisory Board
Director, The Sidney Kimmel Compreheusive Cancer Center at Johns Hopkins and Professor of Oncology and Medicine, The Johns Hopkins Hospitals; President of the American Society of Clinical Oncology (1991); Former Chairman, FDA Oncology Drug Advisory Committee.
Stephen B. Baylin, M.D. Associate Director, The Sidney Kimmel Compreheusive Cancer Center at Johns Hopkins; Director of Tumor Biology Laboratory; Professor of Oncology and Medicine, The Johns Hopkins University and School of Medicine.
Daniel L. Comins, Ph.D. Professor of Organic Chemistry, North Carolina State University; Minerva Award Recipient, SUNY-Potsdam, 1997; Japan Society for the Promotion of Science Fellow, 1998; Associate Editor, Journal of Organic Chemistry
Ross C. Donehower, M.D. Director of Medical Oncology, The Sidney Kimmel Compreheusive Cancer Center at Johns Hopkins, and Associate Professor of Oncology and Medicine, The Johns Hopkins Hospitals; Member, U.S. Pharmacopeia Drug Advisory Panel for Hematologic and Neoplastic Disease.
Anthony M. Guarino, Ph.D. Former FDA Oncology Pharmacology and Toxicology Reviewer; Professor of Pharmacology, the University of South Alabama.
Herbert M. Pinedo, M.D., Ph.D. Head of Department of Medical Oncology and Professor of Medical Oncology, Free University Hospital (The Netherlands); Head of the European Organization for the Research and Treatment of Cancer (EORTC); Former President of the European Society of Medical Oncology (ESMO).
Youcef M. Rustum, Ph.D. Senior Vice President for Scientific Affairs at Grace Cancer Drug Center, Roswell Park Cancer Institute.
Rein Saral, M.D. Professor of Medicine, Emory University School of Medicine; Senior Associate Director, The Winship Cancer Institute of Emory University; Associate Medical Director, Emory Hospitals
Richard L. Schilsky, M.D. Associate Dean for Clinical Research, University of Chicago; Chairman, Cancer & Leukemia Group B; Former Chairman, FDA Oncology Drug Advisory Committee.
